|

BL-M14D1 Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 1: 2

Top Sponsors

  • SystImmune Inc.1
  • Sichuan Baili Pharmaceutical Co., Ltd.1

Indications

  • Lung Cancer2
  • Cancer2
  • Metastatic Large Cell Neuroendocrine Carcinoma of the Lung1
  • Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine1
  • Locally Advanced Neuroendocrine Prostate Cancer1

Other1 trial

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors
Phase 1

Huntsville, Alabama1 trial

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Clearview Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.